A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 75 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
If female, non pregnant, BMI less than 40 kg/m2
Patient has chronic, stable hepatic insufficiency
Patient unwilling to refrain from alcohol and grapefruit juice prior to and shortly after study drug administration
Patient has diabetes, had a heart attack or stroke, or uncontrolled congestive heart failure during the past 6 months
Patient has a history of drug or alcohol abuse
Patient smokes > 10 cigarettes per day
Patient consumes more that 6 cups of caffeinated beverages per day
Patient has had surgery, donated blood or participated in another clinical trial within the past 4 weeks